Berberine reverses lapatinib resistance of HER2-positive breast cancer cells by increasing the level of ROS.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27416292)

Published in Cancer Biol Ther on July 14, 2016

Authors

Ruohan Zhang1,2, Hongyu Qiao3, Suning Chen4, Xu Chen5, Kefeng Dou2, Li Wei6, Jian Zhang1

Author Affiliations

1: a The State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology , The Fourth Military Medical University , Xi'an, Shaanxi , China.
2: b Department of Hepato-Biliary and Pancreto-Splenic Surgery , Xijing Hospital, The Fourth Military Medical University , Xi'an , China.
3: c Department of Cardiology , Xijing Hospital, The Fourth Military Medical University , Xi'an , China.
4: d Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University , Xi'an , China.
5: e Cadet Brigade of the Fourth Military Medical University, The Fourth Military Medical University , Xi'an , China.
6: f Department of Obstetrics and Gynecology , Xijing Hospital, The Fourth Military Medical University , Xi'an , China.

Articles citing this

Reactive Oxygen Species-Mediated Mechanisms of Action of Targeted Cancer Therapy. Oxid Med Cell Longev (2017) 0.75

Articles cited by this

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (1989) 31.55

Untangling the ErbB signalling network. Nat Rev Mol Cell Biol (2001) 28.05

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature (2011) 9.70

Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells. Cancer Res (2006) 7.18

Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci U S A (2001) 6.78

A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells. Cancer Res (2004) 6.53

ROS stress in cancer cells and therapeutic implications. Drug Resist Updat (2004) 5.20

Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc Natl Acad Sci U S A (1996) 5.15

Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev (2006) 4.71

An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen. Proc Natl Acad Sci U S A (2001) 4.49

The effects of the novel, reversible epidermal growth factor receptor/ErbB-2 tyrosine kinase inhibitor, GW2016, on the growth of human normal and tumor-derived cell lines in vitro and in vivo. Mol Cancer Ther (2001) 4.37

Treatment of HER2-positive breast cancer: current status and future perspectives. Nat Rev Clin Oncol (2011) 4.12

High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol Sci (2001) 4.02

Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways. Oncogene (2002) 3.87

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis (2008) 3.19

Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL. Cancer Res (2009) 3.10

Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med (2000) 2.98

Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. Lancet Oncol (2013) 2.59

Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust. Toxicol Appl Pharmacol (2001) 2.40

Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Cancer Res (2004) 2.23

Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema. Genes Cells (2005) 2.18

Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2. Cancer Res (2008) 2.04

Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res (2008) 1.98

Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol (2009) 1.86

Genomics-based prognosis and therapeutic prediction in breast cancer. J Natl Compr Canc Netw (2005) 1.59

The mitochondrial ATPase inhibitory factor 1 triggers a ROS-mediated retrograde prosurvival and proliferative response. Mol Cell (2012) 1.46

Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/β-TrCP axis. Mol Cell Biol (2012) 1.28

Lapatinib in the treatment of breast cancer. Expert Rev Anticancer Ther (2007) 1.16

Effects of fluoride on DNA damage, S-phase cell-cycle arrest and the expression of NF-kappaB in primary cultured rat hippocampal neurons. Toxicol Lett (2008) 1.15

Mechanism of the Nrf2/Keap1/ARE signaling system. Biochemistry (Mosc) (2011) 1.13

Disruption of Nrf2 enhances susceptibility to airway inflammatory responses induced by low-dose diesel exhaust particles in mice. Clin Immunol (2008) 1.12

Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus. Evid Based Complement Alternat Med (2014) 1.10

Mitochondria and reactive oxygen species. Which role in physiology and pathology? Adv Exp Med Biol (2012) 1.07

Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells. Cancer Res (2007) 1.03

Coptis extracts enhance the anticancer effect of estrogen receptor antagonists on human breast cancer cells. Biochem Biophys Res Commun (2008) 1.01

Disruption of Nrf2 enhances the upregulation of nuclear factor-kappaB activity, tumor necrosis factor-α, and matrix metalloproteinase-9 after spinal cord injury in mice. Mediators Inflamm (2010) 0.94

Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling. J Cell Mol Med (2013) 0.93

Resistance to HER2 inhibitors: is addition better than substitution? Rationale for the hypothetical concept of drug sedimentation. Crit Rev Oncol Hematol (2010) 0.90

Berberine diminishes the side population and ABCG2 transporter expression in MCF-7 breast cancer cells. Planta Med (2008) 0.89

RON confers lapatinib resistance in HER2-positive breast cancer cells. Cancer Lett (2013) 0.88

Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cells. J Surg Res (2011) 0.86

Berberine-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species generation and mitochondrial-related apoptotic pathway. Tumour Biol (2014) 0.85

An Epigenetic Pathway Regulates Sensitivity of Breast Cancer Cells to HER2 Inhibition via FOXO/c-Myc Axis. Cancer Cell (2015) 0.84

Enhanced PI3K p110α signaling confers acquired lapatinib resistance that can be effectively reversed by a p110α-selective PI3K inhibitor. Mol Cancer Ther (2013) 0.83

Enhancement of Arsenic Trioxide (As(2)O(3))- Mediated Apoptosis Using Berberine in Human Neuroblastoma SH-SY5Y Cells. J Korean Neurosurg Soc (2007) 0.82

ROS-PIASγ cross talk channelizes ATM signaling from resistance to apoptosis during chemosensitization of resistant tumors. Cell Death Dis (2014) 0.82

Protective autophagy promotes the resistance of HER2-positive breast cancer cells to lapatinib. Tumour Biol (2015) 0.80

Berberine Regulated Lipid Metabolism in the Presence of C75, Compound C, and TOFA in Breast Cancer Cell Line MCF-7. Evid Based Complement Alternat Med (2015) 0.79

3,5,3'-triiodothyronine (T3) stimulates cell proliferation through the activation of the PI3K/Akt pathway and reactive oxygen species (ROS) production in chick embryo hepatocytes. Steroids (2012) 0.79

Anthelmintic activity of berberine hydrochloride against Syphacia obvelata in mice. Indian J Exp Biol (1976) 0.77